Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells
- 1 January 1997
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 42 (2) , 103-112
- https://doi.org/10.1023/a:1005725203159
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancerPublished by Elsevier ,1994
- Enhancement of cisplatin activity by lonidamine in human ovarian cancer cellsInternational Journal of Cancer, 1992
- Reversal of adriamycin resistance by lonidamine in a human breast cancer cell lineBritish Journal of Cancer, 1991
- Inhibition of the recovery from potentially lethal damage by lonidamineBritish Journal of Cancer, 1984
- Phase I and Clinical Pharmacologic Evaluation of Lonidamine in Patients with Advanced CancerOncology, 1984
- A Long-Term Clinical Experience with LonidamineOncology, 1984
- Establishment and characterization of a cell line of human breast carcinoma originPublished by Elsevier ,1979
- A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2JNCI Journal of the National Cancer Institute, 1973